Dr. Luca Szalontay, MD
Claim this profileNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
About Luca Szalontay, MD
Education:
- Earned an MD from Columbia University Vagelos College of Physicians and Surgeons in 2017.
- Completed a Residency in Internal Medicine at NewYork-Presbyterian/Columbia University Medical Center in 2021.
- Undertook a Fellowship in Hematology and Oncology at Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian/Columbia University Medical Center, expected completion in 2024.
Experience:
- Specialized training in Internal Medicine, Hematology, and Oncology at NewYork-Presbyterian/Columbia University Medical Center.
Area of expertise
Cancer
Luca Szalontay, MD has run 13 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Luca Szalontay, MD has run 12 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Columbia University Medical Center
Clinical Trials Luca Szalontay, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting
1 award
Phase 1 & 2
13 criteria
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting
1 award
Phase 3
More about Luca Szalontay, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Luca Szalontay, MD has experience with
- Larotrectinib
- Tipifarnib
- Selpercatinib
- ONC201
- MTX110
- Convection-Enhanced Delivery (CED)
Breakdown of trials Luca Szalontay, MD has run
Cancer
Solid Tumors
Brain Tumor
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luca Szalontay, MD specialize in?
Luca Szalontay, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are APC negative.
Is Luca Szalontay, MD currently recruiting for clinical trials?
Yes, Luca Szalontay, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Luca Szalontay, MD has studied deeply?
Yes, Luca Szalontay, MD has studied treatments such as Larotrectinib, Tipifarnib, Selpercatinib.
What is the best way to schedule an appointment with Luca Szalontay, MD?
Apply for one of the trials that Luca Szalontay, MD is conducting.
What is the office address of Luca Szalontay, MD?
The office of Luca Szalontay, MD is located at: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York 10032 United States. This is the address for their practice at the NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.